While more suited for aggressive investors, and with the number of new traders skyrocketing over the past year and making good ideas to trade even harder to find, these could prove exciting additions for traders looking for solid alpha potential,” says the author of today’s article of the five Buy-rated stocks currently trading under $10 that he proceeds to highlight. For these five stocks, CLICK HERE.
Category: ZenMoney News
4 Tech Stocks To Watch As Investors Go Back To Last Year’s Playbook
With the daily average coronavirus cases being above 150,000 in the U.S., investors have been going back to the old playbook that worked so well last year. This could explain why the tech sector is still performing so well,” notes the author of today’s article before proceeding to highlight four tech stocks in particular to watch this week. For these four stocks, CLICK HERE.
Better Know These Lesser-Known Biotech Stocks That Have Been Surging
As the biotech sector has received increased investor focus over the past year amid the COVID-19 pandemic, the author of today’s article notes that “Even the smaller and lesser known are being seen now as having immense potential; Many of these companies are working tirelessly toward new drug developments and eyeing larger collaborations.” With that, she proceeds to highlight three lesser-known biotech stocks that have been surging over the past year – and that appear poised for even more upside. For more, CLICK HERE.
5 Buy-Rated Stocks Priced Under $10 Offering Solid Alpha Potential
“While more suited for aggressive investors, and with the number of new traders skyrocketing over the past year and making good ideas to trade even harder to find, these could prove exciting additions for traders looking for solid alpha potential,” says the author of today’s article in regards to five Buy-rated stocks priced under $10 that he proceeds to highlight. For these five stocks – including an “off-the-radar company [with] the potential to be a huge winner with the new administration signaling possible marijuana legalization” – CLICK HERE.
“In A League Of Its Own”: This Immuno-Oncology Stock’s Great Run In 2020 May Have Just Been The Beginning
Trillium Therapeutics surged 1,330% last year – and as an immuno-oncology company, its performance had nothing to do with COVID-19 related catalysts. Moreover, its 2020 run may have just been the beginning, as the company’s cancer-fighting candidates – which it hopes will ultimately replace chemotherapy as the dominant type of cancer treatment – are, as today’s article explains, currently in a league of their own. For more, CLICK HERE.
Top Stock Picks For Aggressive Growth Investors In 2021
“These four look like solid picks for more aggressive growth investors as they have significant catalysts that can drive growth for the rest of 2021 and beyond,” says the author of today’s article in regards to the four stocks he proceeds to highlight, each of which is a top growth stock call for 2021 from Jefferies. For these four stocks – which include a company that could benefit from the rollout of COVID-19 vaccines – CLICK HERE.
A Diamond In The Rough & 2 Other Top Biotech Stock Picks For 2021
One of the strongest biotechs out there, a diamond in the rough, and a high-risk, high-reward play make up the three biotech stocks identified by the author of today’s article as top picks for 2021 for investors looking for even better biotech returns than those offered by broad biotech ETFs such as the SPDR S&P Biotech ETF. For a look at these three biotech stocks, CLICK HERE.
With Many Psychedelic Stocks Posting Triple-Digit Returns, The “Shroom Boom” May Just Be Beginning
While biotech stocks have been hot over the last year, today’s article notes that another group of stocks have been trading like biotech companies of late: psychedelic stocks. In fact, a slew of psychedelic stocks have posted triple-digit returns over the last year – and with the impending release of studies examining the use of psychedelics to treat mental health disorders, the “shroom boom” may just be beginning. For more, CLICK HERE.
2021 Is Sure To Bring New Problems Requiring More Tech – And These 3 Stocks Could Benefit
While many are hopeful that 2021 will bring better times than 2020, there’s much we don’t know about what this new year has in store. One thing we do know, points out the author of today’s article, is that “there will be new problems needing more tech, and tech investors are ever-ready to pounce when that time comes.” As such, he proceeds to take a look at what may be three of the best tech stocks to watch right now. For these three stocks, CLICK HERE.
These 3 Tech Stocks Missed Out On 2020’s Rally – But Could Deliver Huge Growth In 2021
The thing that created the conditions that made 2020 so awful for so many – the coronavirus pandemic – also created the conditions for tech to stage an impressive rally. The three promising tech stocks highlighted in today’s article, however, did not participate in that rally. As a result, these underperforming stocks “still trade at levels that leave room for huge growth” and “could turn things around and deliver fantastic returns to shareholders in 2021.” For these three stocks, CLICK HERE.
